` PNAX (Panaxia Labs Israel Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

PNAX
vs
Tel Aviv 355

Over the past 12 months, PNAX has underperformed Tel Aviv 355, delivering a return of -23% compared to the Tel Aviv 355's 47% growth.

Stocks Performance
PNAX vs Tel Aviv 355

Loading
PNAX
Tel Aviv 355
Add Stock
www.alphaspread.com

Performance Gap
PNAX vs Tel Aviv 355

Loading
PNAX
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
PNAX vs Tel Aviv 355

Loading
PNAX
Tel Aviv 355
Add Stock

Competitors Performance
Panaxia Labs Israel Ltd vs Peers

Tel Aviv 355
PNAX
LLY
JNJ
NOVO B
ROG
Add Stock

Panaxia Labs Israel Ltd
Glance View

Market Cap
7.9m ILS
Industry
Pharmaceuticals

Panaxia Labs Israel Ltd. engages in the manufacture and distribution of medical cannabis products. The firm provides pharma-grade smokeless cannabis products that provide better delivery systems for patients and physicians when properly assessing safety and dosage. Panaxia pharmaceutical cannabis products are specifically tailored to meet a broad range of needs. It's product portfolio includes: NAXIVA-PANAXOL Advanced kit for preparation of cannabis oil-standardized extract, NAXIVA-PANAXOL Purified extract for inhalation, PANAXIR Medical Cannabis Orodispersible Tablets, PANAXIR SENSE Orange Creamsicle Medical cannabis sublingual drops, PANAXIR CBD Melatonin Tablets, PANAXIR Medical cannabis extracts in ethanol among others.

PNAX Intrinsic Value
Not Available
P
Back to Top